Wall Street is looking to dental care companies for signs of a stronger 2026, though analysts caution that a full industry rebound may still be some way off.
Major players, including Henry Schein (HSIC.O), Align Technology (ALGN.O), Envista (NVST.N), and Dentsply Sirona (XRAY.O), reported a turbulent 2025, with dental visits fluctuating throughout the year. While there are early signs of demand recovery, the volatility has left investors wary.
“The general expectation is for steady messaging and better—or less bad—results,” said Michael Cherny, analyst at Leerink. He noted that while the factors behind last summer’s weakness appear to have stabilized, there has not been any significant acceleration.
At least four analysts forecast relatively stable U.S. dental demand in 2026, a marked improvement from the “roller-coaster” swings of recent years. However, stability should not be confused with a full recovery.
“The market generally remains soft, with demand for expensive procedures still depressed,” said Lilia-Celine B. Lozada, J.P. Morgan analyst. She expects management teams to issue conservative forecasts to maintain predictable performance throughout the year.
There are some bright spots. Patient volumes are gradually rising, and demand for clear aligners has strengthened, though affordability concerns persist. Seasonal and year-end spending also provided a boost in the fourth quarter.
Despite these gains, confidence in a sustained rebound remains fragile. Rising prices, labor market uncertainties, and shifting consumer sentiment continue to affect discretionary dental care.
“The consumer in dental is very fickle. One policy change or even a tweet can quickly erase optimism,” said Brandon Vazquez, analyst at William Blair.